142 related articles for article (PubMed ID: 32088184)
1. Phototoxic risk assessment of dermally-applied chemicals with structural variety based on photoreactivity and skin deposition.
Seto Y; Ohtake H; Sato H; Onoue S
Regul Toxicol Pharmacol; 2020 Jun; 113():104619. PubMed ID: 32088184
[TBL] [Abstract][Full Text] [Related]
2. Phototoxic Risk Assessments on Benzophenone Derivatives: Photobiochemical Assessments and Dermal Cassette-Dosing Pharmacokinetic Study.
Seto Y; Ohtake H; Kato M; Onoue S
J Pharmacol Exp Ther; 2015 Aug; 354(2):195-202. PubMed ID: 26016852
[TBL] [Abstract][Full Text] [Related]
3. Photosafety screening of phenothiazine derivatives with combined use of photochemical and cassette-dosing pharmacokinetic data.
Onoue S; Kato M; Inoue R; Seto Y; Yamada S
Toxicol Sci; 2014 Feb; 137(2):469-77. PubMed ID: 24241722
[TBL] [Abstract][Full Text] [Related]
4. Photochemical and Pharmacokinetic Characterization of Orally Administered Chemicals to Evaluate Phototoxic Risk.
Iyama Y; Sato H; Seto Y; Onoue S
J Pharm Sci; 2019 Mar; 108(3):1303-1308. PubMed ID: 30336153
[TBL] [Abstract][Full Text] [Related]
5. A new photosafety screening strategy based on in chemico photoreactivity and in vitro skin exposure for dermally-applied chemicals.
Iyama Y; Sato H; Seto Y; Onoue S
Toxicol Lett; 2019 Dec; 317():45-52. PubMed ID: 31557510
[TBL] [Abstract][Full Text] [Related]
6. Strategic photosafety screening system consisting of in chemico photoreactivity and in vitro skin exposure for quinolone derivatives.
Iyama Y; Sato H; Seto Y; Onoue S
Eur J Pharm Sci; 2020 Apr; 146():105257. PubMed ID: 32035110
[TBL] [Abstract][Full Text] [Related]
7. An approach to evaluate metabolite-related phototoxicity with combined use of photochemical properties and skin deposition.
Seto Y; Tonami R; Iyama Y; Sato H; Onoue S
Toxicol Lett; 2021 Oct; 350():91-97. PubMed ID: 34265374
[TBL] [Abstract][Full Text] [Related]
8. New Photosafety Assessment Strategy Based on the Photochemical and Pharmacokinetic Properties of Both Parent Chemicals and Metabolites.
Kato M; Suzuki G; Ohtake H; Seto Y; Onoue S
Drug Metab Dispos; 2015 Nov; 43(11):1815-22. PubMed ID: 26296710
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.
Onoue S; Kawamura K; Igarashi N; Zhou Y; Fujikawa M; Yamada H; Tsuda Y; Seto Y; Yamada S
J Pharm Biomed Anal; 2008 Aug; 47(4-5):967-72. PubMed ID: 18455898
[TBL] [Abstract][Full Text] [Related]
10. Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.
Seto Y; Inoue R; Ochi M; Gandy G; Yamada S; Onoue S
AAPS J; 2011 Sep; 13(3):482-92. PubMed ID: 21739333
[TBL] [Abstract][Full Text] [Related]
11. Non-animal photosafety assessment approaches for cosmetics based on the photochemical and photobiochemical properties.
Onoue S; Suzuki G; Kato M; Hirota M; Nishida H; Kitagaki M; Kouzuki H; Yamada S
Toxicol In Vitro; 2013 Dec; 27(8):2316-24. PubMed ID: 24134854
[TBL] [Abstract][Full Text] [Related]
12. Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization.
Seto Y; Inoue R; Kato M; Yamada S; Onoue S
J Photochem Photobiol B; 2013 Mar; 120():44-51. PubMed ID: 23419534
[TBL] [Abstract][Full Text] [Related]
13. Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation.
Onoue S; Hosoi K; Wakuri S; Iwase Y; Yamamoto T; Matsuoka N; Nakamura K; Toda T; Takagi H; Osaki N; Matsumoto Y; Kawakami S; Seto Y; Kato M; Yamada S; Ohno Y; Kojima H
J Appl Toxicol; 2013 Nov; 33(11):1241-50. PubMed ID: 22696462
[TBL] [Abstract][Full Text] [Related]
14. Development of an albuminous reactive oxygen species assay for photosafety evaluation under experimental biomimetic conditions.
Onoue S; Kato M; Yamada S
J Appl Toxicol; 2014 Feb; 34(2):158-65. PubMed ID: 23355082
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic reactive oxygen species assay to evaluate phototoxic risk of metabolites.
Kato M; Ohtake H; Sato H; Seto Y; Onoue S
Toxicol Lett; 2017 Aug; 278():59-65. PubMed ID: 28698097
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of skin phototoxicity study using SD rats by transdermal and oral administration.
Yonezawa Y; Ohsumi T; Miyashita T; Kataoka A; Hashimoto K; Nejishima H; Ogawa H
J Toxicol Sci; 2015 Dec; 40(6):667-83. PubMed ID: 26558448
[TBL] [Abstract][Full Text] [Related]
17. In vitro photosafety and efficacy screening of apigenin, chrysin and beta-carotene for UVA and VIS protection.
Freitas JV; Gaspar LR
Eur J Pharm Sci; 2016 Jun; 89():146-53. PubMed ID: 27130544
[TBL] [Abstract][Full Text] [Related]
18. In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors.
Seto Y; Onoue S; Yamada S
Eur J Pharm Sci; 2009 Sep; 38(2):104-11. PubMed ID: 19576281
[TBL] [Abstract][Full Text] [Related]
19. Phototoxicity Evaluation of Pharmaceutical Substances with a Reactive Oxygen Species Assay Using Ultraviolet A.
Lee YS; Yi JS; Lim HR; Kim TS; Ahn IY; Ko K; Kim J; Park HK; Sohn SJ; Lee JK
Toxicol Res; 2017 Jan; 33(1):43-48. PubMed ID: 28133512
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species (ROS) assay-based photosafety screening for complex ingredients: Modification of the ROS assay protocol.
Ohtake H; Tokuyoshi Y; Iyama Y; Nukaga T; Nishida H; Ohtake T; Hirota M; Yamada K; Seto Y; Sato H; Kouzuki H; Onoue S
J Toxicol Sci; 2022; 47(11):483-492. PubMed ID: 36328538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
